Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Duke Energy Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Duke Energy Corp trades at $125.93 (market cap $97.82B). The key difference: Duke Energy Corp pays a 3.39% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Duke Energy Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | DUK | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $133.46 |
52-Week Low | $23.09 | $113.99 |
Market Cap | — | $97.82B |
Enterprise Value | — | $187.87B |
Dividend Yield | — | 3.39% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Duke Energy (DUK) trades at $125.48, up 0.18% on the day, with a bearish technical signal despite recent earnings beats. The stock shows stable revenue growth to $32.24B in 2025 and a net income margin of 15.49%, supported by a dividend yield from its recent $1.07 payout. Analyst consensus is mixed with 40.6% buy ratings and a $137.67 price target, indicating potential upside. Technical resistance sits at $127, with support at $124.
DUK offers defensive appeal with consistent profitability and dividend reliability, but faces headwinds from high debt levels (46.17% debt-to-asset ratio) and capital-intensive infrastructure demands. The stock's neutral RSI and bearish moving averages suggest near-term consolidation, while long-term growth hinges on execution in a regulated utility environment amid rising data center energy demand.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →